|
|
|
|
Michael W. Bonney is a businessperson who has been at the head of 5 different companies. Presently, Mr. Bonney is Chairman at Magenta Therapeutics, Inc., Chairman at Alnylam Pharmaceuticals, Inc. and Chairman for Kaleido Biosciences, Inc. Mr. Bonney is also on the board of Bristol Myers Squibb Co., Gulf of Maine Research Institute, Life Sciences Cares and X-Biotix Therapeutics, Inc. and Chairman for Bates College.
He previously held the position of Director-National Business at Zeneca Pharmaceuticals, Partner at Third Rock Ventures LLC, Vice President-Sales & Marketing at Biogen, Inc., Director at Cubist Pharmaceuticals LLC and Director at Biotechnology Innovation Organization.
Michael W. Bonney received an undergraduate degree from Bates College.
|
| Aktuelle Stellungen und Verantwortungsbereiche Michael Bonney | |
|
|
| Anteile an Michael Bonney | |
|
|
| Michael Bonney : Persönliches Netzwerk | |
|
| Name | Verbundene Unternehmen |
| David Pyott | Alnylam Pharmaceuticals, Inc. |
| Steven Marc Paul | Alnylam Pharmaceuticals, Inc. |
| Margaret A. Hamburg | Alnylam Pharmaceuticals, Inc. |
| Laurie Bartlett Keating | Alnylam Pharmaceuticals, Inc. |
| Amy W. Schulman | Alnylam Pharmaceuticals, Inc. |
| Phillip A. Sharp | Alnylam Pharmaceuticals, Inc. |
| John Maraganore | Alnylam Pharmaceuticals, Inc. |
| Dennis Arthur Ausiello | Alnylam Pharmaceuticals, Inc. |
| Muthiah Manoharan | Alnylam Pharmaceuticals, Inc. |
| Colleen F. Reitan | Alnylam Pharmaceuticals, Inc. |
|
© 2021 People and Ownership : 
|
|
|
| Michael Bonney : Verbindungen | |
|
|
| Aktuelle Nachrichten zu Michael Bonney | |
|
- Keine Nachrichten - |
|
Canada
Deutschland
España
France
Italia
United Kingdom
United States
